Response by Trifan et al to Letter Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials"

Circulation. 2021 Dec 14;144(24):e493-e494. doi: 10.1161/CIRCULATIONAHA.121.057471. Epub 2021 Dec 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Ischemic Attack, Transient*
  • Platelet Aggregation Inhibitors / adverse effects
  • Stroke* / drug therapy
  • Stroke* / prevention & control

Substances

  • Platelet Aggregation Inhibitors